Today

Agents

Chat

Arena

Discover

More

App

X4 Pharmaceuticals Q2 Operating Expenses USD 25.197 Million - XFOR News | Rallies

X4 Pharmaceuticals Q2 Operating Expenses USD 25.197 Million

XFOR•2026-08-06

Q2 operating expenses and profitability

Aug. 6 (Reuters) - X4 Pharmaceuticals Q2 income from operations USD -16.391 million.

Q2 net income USD -16.157 million

Related News

Trump unveils trade actions to protect key solar and semiconductor material

TAN•2026-08-06

Reliance Global sells 251,666 shares to White Lion Capital for about $716,000

RELI•2026-08-06

VAALCO Energy declares Q3 2026 dividend of $0.0625 per share

EGY•2026-08-06

X

Canada's CAPREIT Q2 revenue slightly beats driven by increased monthly rents on lease renewals

XLRE•2026-08-06

Roku beats quarterly revenue estimates on advertising, subscriptions strength

ROKU•2026-08-06